Affordable Access

Publisher Website

Improved in silico prediction of carcinogenic potency (TD50) and the risk specific dose (RSD) adjusted Threshold of Toxicological Concern (TTC) for genotoxic chemicals and pharmaceutical impurities

Authors
Journal
Regulatory Toxicology and Pharmacology
0273-2300
Publisher
Elsevier
Volume
59
Issue
1
Identifiers
DOI: 10.1016/j.yrtph.2010.09.016
Keywords
  • Ttc
  • Threshold Of Toxicological Concern
  • Genotoxic
  • Mutagenic
  • Impurities
  • Qsar
  • Sar
  • Td50
  • Pharmaceuticals
  • Food Contact Substances
  • Rsd
  • Carcinogenicity
Disciplines
  • Pharmacology

Abstract

Abstract The Threshold of Toxicological Concern (TTC) is a level of exposure to a genotoxic impurity that is considered to represent a negligible risk to humans. The TTC was derived from the results of rodent carcinogenicity TD50 values that are a measure of carcinogenic potency. The TTC currently sets a default limit of 1.5μg/day in food contact substances and pharmaceuticals for all genotoxic impurities without carcinogenicity data. Bercu et al. (2010) used the QSAR predicted TD50 to calculate a risk specific dose (RSD) which is a carcinogenic potency adjusted TTC for genotoxic impurities. This promising approach is currently limited by the software used, a combination of MC4PC (www.multicase.com) and a Lilly Inc. in-house software (VISDOM) that is not available to the public. In this report the TD50 and RSD were predicted using a commercially available software, SciQSAR (formally MDL-QSAR, www.scimatics.com) employing the same TD50 training data set and external validation test set that was used by Bercu et al. (2010). The results demonstrate the general applicability of QSAR predicted TD50 values to determine the RSDs for genotoxic impurities and the improved performance of SciQSAR for predicting TD50 values.

There are no comments yet on this publication. Be the first to share your thoughts.